These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37827488)

  • 1. Longitudinal unraveling: The impact of recombinant human growth hormone on spontaneous brain activity in children with short stature-A resting-state fMRI study.
    Shen L; Lin X; Wang C; Chen X; Li J; Wang W; Tang J; Shan X; Yan Z; Lu Y
    J Neuroradiol; 2024 Jun; 51(4):101159. PubMed ID: 37827488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of different doses of recombinant human growth hormone in the treatment of short stature in children born small for gestational age].
    Qie D; Yang F
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):247-53. PubMed ID: 26975824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal amplitude of spontaneous low-frequency fluctuation in children with growth hormone deficiency: A resting-state functional magnetic resonance imaging study.
    Zhang F; Hua B; Wang T; Wang M; Ding ZX; Ding JR
    Neurosci Lett; 2021 Jan; 742():135546. PubMed ID: 33290838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Neural Activity in Children With Diffuse Intrinsic Pontine Glioma Had Manifested Deficit in Behavioral Inhibition: A Resting-State Functional MRI Study.
    Cheng X; Gao PY
    J Comput Assist Tomogr; 2019; 43(4):547-552. PubMed ID: 31162235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Human Growth Hormone Ameliorates Cognitive Impairment in Stroke Patients.
    Feng X; Li G; Wu W; Xu Y; Lin H; Fan J
    J Comput Assist Tomogr; 2020; 44(2):255-261. PubMed ID: 32195805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
    Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting-state Amplitude of Low-frequency Fluctuation is a Potentially Useful Prognostic Functional Biomarker in Cervical Myelopathy.
    Takenaka S; Kan S; Seymour B; Makino T; Sakai Y; Kushioka J; Tanaka H; Watanabe Y; Shibata M; Yoshikawa H; Kaito T
    Clin Orthop Relat Res; 2020 Jul; 478(7):1667-1680. PubMed ID: 32011371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
    Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
    Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting PEGylated growth hormone in children with idiopathic short stature.
    Luo X; Zhao S; Yang Y; Dong G; Chen L; Li P; Luo F; Gong C; Xu Z; Xu X; Gong H; Du H; Hou L; Zhong Y; Shi Q; Chen X; Chen X; Xu L; Cheng R; Su C; Ma Y; Xu L; Zhang L; Lu H
    Eur J Endocrinol; 2022 Nov; 187(5):709-718. PubMed ID: 36130048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
    Liu S; Chen M; Yang H; Chen S; Wang L; Duan L; Zhu H; Pan H
    Front Endocrinol (Lausanne); 2021; 12():776835. PubMed ID: 34956087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short stature and growth hormone use in pediatric hemodialysis patients.
    Gorman G; Fivush B; Frankenfield D; Warady B; Watkins S; Brem A; Neu A
    Pediatr Nephrol; 2005 Dec; 20(12):1794-800. PubMed ID: 16133065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.